ArticleScientific reports2026
The effect of macromolecular crowders as a supplement to serum free media on human corneal stromal cells proliferation and marker expression.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Native human corneal stromal keratocytes (HCSKs) deposit extracellular matrix (ECM) to maintain corneal homeostasis, repair, and regeneration. Adding macromolecular crowders (MMCs) to culture media encourages HCSKs to produce ECM in vitro. However, MMCs may also be used as serum or growth factor replacement for the in vitro culture of cells. This could control phenotype and reduce the cost of future industrial-scale production of cells such as HCSKs for predicted therapeutic applications in corneal repair. To identify the effects of adding (MMCs) to a serum-free medium and the possible role of MMCs in supporting the growth of HCSKs in an undifferentiated phenotype. Primary HCSKs isolated from human corneas were cultured in serum-free media supplemented with different concentrations of MMCs additive (0%, 4%, and 8%). The influence of the MMCs on proliferation and protein expression was investigated using quantitative colorimetric analysis. The addition of MMCs increased cell proliferation and enhanced expression of quiescent keratocyte markers such as ALDH3A1 and Collagen V. It also downregulated stromal fibroblasts’ specific marker, metalloprotease 2 (MMP2), and α smooth muscle actin. These results indicate that adding MMCs to serum-free media significantly supported cell behaviour. In addition, its presence suggested the retention of native quiescent markers when expanded ex vivo. Moreover, the addition of MMCs to serum-free media enhances human corneal keratocyte proliferation and ECM content, but its effects vary based on media glucose concentration. In standard glucose media, MMCs boost cell proliferation and increase collagen V expression as an indicator for robust ECM; however, there is a higher risk of fibroblastic transformation. In serum-free media, MMCs support a quiescent keratocyte phenotype, reduce metabolic stress, and better mimic the native corneal environment, making it more suitable for regenerative applications.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.